Healthy Skepticism Library item: 16027
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: news
O'Connell V, Wang SS.
J&J Acts Fast on Tylenol
The Wall Street Journal 2009 Jul 9
http://online.wsj.com/article/SB124709897531615407.html
Abstract:
The Challenge: to Reassure Public Without Going Too Far
Full text:
Johnson & Johnson’s quick reaction last week to potentially damaging news about the safety of its painkiller Tylenol furthered the company’s reputation for savvy crisis management. But the going is likely to get tougher in the months ahead.
Experts say J&J will have to walk a fine line between reassuring the public that its pills are safe without overstating its case and stirring up criticism.
On July 3, just three days after a Food and Drug Administration advisory panel recommended sweeping limits on acetaminophen, the generic name for Tylenol and some of its rivals, J&J ran full-page ads in USA …
